Bioorganic and Medicinal Chemistry Letters p. 5633 - 5637 (2011)
Update date:2022-08-02
Topics:
Zhang, Lin
Fan, Junhua
Chong, Jer-Hong
Cesena, Angela
Tam, Betty Y.Y.
Gilson, Charles
Boykin, Christina
Wang, Deping
Aivazian, Dikran
Marcotte, Doug
Xiao, Guangqing
Le Brazidec, Jean-Yves
Piao, Jinhua
Lundgren, Karen
Hong, Kevin
Vu, Khang
Nguyen, Khanh
Gan, Liang-Shang
Silvian, Laura
Ling, Leona
Teng, Min
Reff, Mitchell
Takeda, Nicole
Timple, Noel
Wang, Qin
Morena, Ron
Khan, Samina
Zhao, Shuo
Li, Tony
Lee, Wen-Cherng
Taveras, Arthur G.
Chao, Jianhua
A novel class of pyrazolopyrimidine-sulfonamides was discovered as selective dual inhibitors of aurora kinase A (AKA) and cyclin-dependent kinase 1 (CDK1). These inhibitors were originally designed based on an early lead (compound I). SAR development has led to the discovery of potent inhibitors with single digit nM IC50s towards both AKA and CDK1. An exemplary compound 1a has demonstrated good efficacy in an HCT116 colon cancer xenograft model.
View MoreHuangshi Shennong Chemical Technology Co., Ltd
Contact:+86-714-3072290
Address:Eastern industrial park , Tieshan district , Huangshi city ,Hubei province , China
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Zhengzhou Minzhong Pharmaceutical Co.,ltd
Contact:0086-371-65797115
Address:15/F,Jiangshan Bldg, NO.126 Huanghe Road,Zhengzhou, China
website:http://www.joyochem.com
Contact:0531-82687998
Address:Factory Building 11, Jinan Comprehensive free trade zone, Shandong, China
shanghai tuomiao chemicial co.,ltd.
website:https://www.tuomiaochem.com/
Contact:021 - 59853336
Address:shanghai
Doi:10.1021/ja01528a035
(1959)Doi:10.1007/s11172-012-0014-9
(2012)Doi:10.1002/jhet.224
(2009)Doi:10.1039/c7tc03931j
(2017)Doi:10.1248/cpb.c17-00828
(2018)Doi:10.1111/cbdd.12185
(2013)